Menu
Menu
In anticipation of FDA approval and medicalization, many clinicians have jumped at the opportunity to be trained in these modalities and others are interested in learning more, but many questions remain unanswered around the current policy landscape, changes needed to welcome these medicines into our current healthcare system and in psychotherapy. This goal of this session is to provide clinicians with an overview of the history and current state of psychedelic policy and the implications for clinicians interested in practicing psychedelic-assisted therapy.
Planning Committee Disclosure - No relevant relationships
All members of the PESI, Inc. planning committee have provided disclosures of financial relationships with ineligible organizations and any relevant non-financial relationships prior to planning content for this activity. None of the committee members had relevant financial relationships with ineligible companies or other potentially biasing relationships to disclose to learners. For speaker disclosures, please see the faculty biography.
PESI Australia, in collaboration with PESI in the USA, offers quality online continuing professional development events from the leaders in the field at a standard recognized by professional associations including psychology, social work, occupational therapy, alcohol and drug professionals, counselling and psychotherapy. On completion of the training, a Professional Development Certificate is issued after the individual has answered and submitted a quiz and course evaluation. This program is worth 1.25 hours CPD for points calculation by your association.
| File type | File name | Number of pages | |
|---|---|---|---|
| Manual - Psychedelic-Assisted Psychotherapies: A Policy Perspective (1.24 MB) | 20 Pages | Available after Purchase | |
| Text Document | Transcript (26.9 KB) | 7 Pages | Available after Purchase |
| Manual - Psychedelic-Assisted Psychotherapies: A Policy Perspective - French (1.24 MB) | 20 Pages | Available after Purchase | |
| Text Document | Transcript - French (26.9 KB) | 7 Pages | Available after Purchase |
| Manual - Psychedelic-Assisted Psychotherapies: A Policy Perspective - Italian (1.24 MB) | 20 Pages | Available after Purchase | |
| Text Document | Transcript - Italian (26.9 KB) | 7 Pages | Available after Purchase |
Victor Cabral, MSW, LSW, CCTP-I, (He/Him/His) is a collaborative and strategic leader who is making an impact on historical inequalities in his community and across the United States. Victor is the Founder of Dreamers of the Day, LLC, and serves as the Director of Policy and Regulatory Affairs for Fluence International Inc., a company that provides evidence-based training in psychedelic therapy and integration services to clinicians across the globe. Before joining Fluence, Victor served as Deputy Director for the Pennsylvania Governor’s Office of Advocacy and Reform where he co-led the implementation of the Trauma-Informed PA Plan, helped establish the first Racial Day of Healing in Pennsylvania history, and developed free trauma trainings for Pennsylvanians in collaboration with BIPOC mental health and trauma, and psychedelic medicine. He is a Licensed Social Worker and practicing psychotherapist in Pennsylvania with training in Internal Family Systems, Psychedelic-Assisted Psychotherapy and Psychedelic Integration.
Speaker Disclosures:
Financial: Victor Cabral is the Director of Policy and Regulatory Affairs at Fluence. He receives a speaking honorarium from PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: Victor Cabral is the Justice, Equity, Diversity, and Inclusion Co-Chair for the American Psychedelic Practitioners Association.
Please wait ...